122 related articles for article (PubMed ID: 26043160)
1. Novel 4-aryl-pyrido[1,2-c]pyrimidines with dual SSRI and 5-HT(1A) activity. Part 5.
Gomółka A; Ciesielska A; Wróbel MZ; Chodkowski A; Kleps J; Dawidowski M; Siwek A; Wolak M; Stachowicz K; Sławińska A; Nowak G; Satała G; Bojarski AJ; Belka M; Ulenberg S; Bączek T; Skowronek P; Turło J; Herold F
Eur J Med Chem; 2015 Jun; 98():221-36. PubMed ID: 26043160
[TBL] [Abstract][Full Text] [Related]
2. Novel 4-aryl-pyrido[1,2-c]pyrimidines with dual SSRI and 5-HT(1A) activity. part 3.
Herold F; Chodkowski A; Izbicki Ł; Turło J; Dawidowski M; Kleps J; Nowak G; Stachowicz K; Dybała M; Siwek A; Mazurek AP; Mazurek A; Pluciński F
Eur J Med Chem; 2011 Jan; 46(1):142-9. PubMed ID: 21093118
[TBL] [Abstract][Full Text] [Related]
3. Synthesis of novel pyrido[1,2-c]pyrimidine derivatives with rigidized tryptamine moiety as potential SSRI and 5-HT
Ślifirski G; Król M; Kleps J; Ulenberg S; Belka M; Bączek T; Siwek A; Stachowicz K; Szewczyk B; Nowak G; Bojarski A; Kozioł AE; Turło J; Herold F
Eur J Med Chem; 2019 Mar; 166():144-158. PubMed ID: 30703658
[TBL] [Abstract][Full Text] [Related]
4. Novel 4-aryl-pyrido[1,2-c]pyrimidines with dual SSRI and 5-HT1A activity, part 1.
Herold F; Chodkowski A; Izbicki Ł; Król M; Kleps J; Turło J; Nowak G; Stachowicz K; Dybała M; Siwek A
Eur J Med Chem; 2009 Apr; 44(4):1710-7. PubMed ID: 18995929
[TBL] [Abstract][Full Text] [Related]
5. Novel 4-aryl-pyrido[1,2-c]pyrimidines with dual SSRI and 5-HT1A activity. Part 4.
Chodkowski A; Wróbel MZ; Turło J; Kleps J; Siwek A; Nowak G; Belka M; Bączek T; Mazurek AP; Herold F
Eur J Med Chem; 2015 Jan; 90():21-32. PubMed ID: 25461308
[TBL] [Abstract][Full Text] [Related]
6. Novel 4-aryl-pyrido[1,2-c]pyrimidines with dual SSRI and 5-HT1A activity: part 2.
Herold F; Izbicki Ł; Chodkowski A; Dawidowski M; Król M; Kleps J; Turło J; Wolska I; Nowak G; Stachowicz K; Dybała M; Siwek A; Nowak M; Pieniazek E; Jarończyk M; Sylte I; Mazurek AP
Eur J Med Chem; 2009 Nov; 44(11):4702-15. PubMed ID: 19665823
[TBL] [Abstract][Full Text] [Related]
7. Synthesis of new 5,6,7,8-tetrahydropyrido[1,2-c]pyrimidine derivatives with rigidized tryptamine moiety as potential SSRI and 5-HT
Ślifirski G; Król M; Kleps J; Podsadni P; Belka M; Bączek T; Siwek A; Stachowicz K; Szewczyk B; Nowak G; Bojarski A; Kozioł AE; Turło J; Herold F
Eur J Med Chem; 2019 Oct; 180():383-397. PubMed ID: 31325785
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of Novel Pyrido[1,2-
Król M; Ślifirski G; Kleps J; Ulenberg S; Belka M; Bączek T; Siwek A; Stachowicz K; Szewczyk B; Nowak G; Duszyńska B; Herold F
Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33652672
[TBL] [Abstract][Full Text] [Related]
9. Synthesis of new hexahydro- and octahydropyrido[1,2-c]pyrimidine derivatives with an arylpiperazine moiety as ligands for 5-HT1A and 5-HT2A receptors. Part 4.
Herold F; Król M; Kleps J; Nowak G
Eur J Med Chem; 2006 Jan; 41(1):125-34. PubMed ID: 16263195
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of new hexahydro- and octahydropyrido[1,2-c]pyrimidine derivatives with an arylpiperazine moiety as ligands for 5-HT(1A) and 5-HT(2A) receptors, Part 2.
Herold F; Kleps J; Nowak G; Maj M
Pharmazie; 2004 Feb; 59(2):99-105. PubMed ID: 15025176
[TBL] [Abstract][Full Text] [Related]
11. Syntheses and binding studies of new [(aryl)(aryloxy)methyl]piperidine derivatives and related compounds as potential antidepressant drugs with high affinity for serotonin (5-HT) and norepinephrine (NE) transporters.
Orjales A; Mosquera R; Toledo A; Pumar MC; García N; Cortizo L; Labeaga L; Innerárity A
J Med Chem; 2003 Dec; 46(25):5512-32. PubMed ID: 14640559
[TBL] [Abstract][Full Text] [Related]
12. New 1-aryl-3-(4-arylpiperazin-1-yl)propane derivatives, with dual action at 5-HT1A serotonin receptors and serotonin transporter, as a new class of antidepressants.
Martínez-Esparza J; Oficialdegui AM; Pérez-Silanes S; Heras B; Orús L; Palop JA; Lasheras B; Roca J; Mourelle M; Bosch A; Del Castillo JC; Tordera R; Del Río J; Monge A
J Med Chem; 2001 Feb; 44(3):418-28. PubMed ID: 11462981
[TBL] [Abstract][Full Text] [Related]
13. Synthesis and molecular modeling of new 1-aryl-3-[4-arylpiperazin-1-yl]-1-propane derivatives with high affinity at the serotonin transporter and at 5-HT(1A) receptors.
Orús L; Pérez-Silanes S; Oficialdegui AM; Martínez-Esparza J; Del Castillo JC; Mourelle M; Langer T; Guccione S; Donzella G; Krovat EM; Poptodorov K; Lasheras B; Ballaz S; Hervías I; Tordera R; Del Río J; Monge A
J Med Chem; 2002 Sep; 45(19):4128-39. PubMed ID: 12213056
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of new hexahydro- and octahydropyrido[1,2-c]pyrimidine derivatives with an arylpiperazine moiety as ligands for 5-HT1A and 5-HT2A receptors. Part III.
Herold F; Król M; Kleps J
Acta Pol Pharm; 2004; 61(2):139-50. PubMed ID: 15493297
[TBL] [Abstract][Full Text] [Related]
15. Synthesis and biological investigation of new equatorial (β) stereoisomers of 3-aminotropane arylamides with atypical antipsychotic profile.
Stefanowicz J; Słowiński T; Wróbel MZ; Herold F; Gomółka AE; Wesołowska A; Jastrzębska-Więsek M; Partyka A; Andres-Mach M; Czuczwar SJ; Łuszczki JJ; Zagaja M; Siwek A; Nowak G; Żołnierek M; Bączek T; Ulenberg S; Belka M; Turło J
Bioorg Med Chem; 2016 Sep; 24(18):3994-4007. PubMed ID: 27377863
[TBL] [Abstract][Full Text] [Related]
16. New arylpiperazine 5-HT(1A) receptor ligands containing the pyrimido[2,1-f]purine fragment: synthesis, in vitro, and in vivo pharmacological evaluation.
Jurczyk S; Kołaczkowski M; Maryniak E; Zajdel P; Pawłowski M; Tatarczyńska E; Kłodzińska A; Chojnacka-Wójcik E; Bojarski AJ; Charakchieva-Minol S; Duszyńska B; Nowak G; Maciag D
J Med Chem; 2004 May; 47(10):2659-66. PubMed ID: 15115407
[TBL] [Abstract][Full Text] [Related]
17. Oncotoxic Properties of Serotonin Transporter Inhibitors and 5-HT
Walory J; Mielczarek L; Jarończyk M; Koronkiewicz M; Kossakowski J; Bugno R; Bojarski AJ; Chilmonczyk Z
Int J Mol Sci; 2018 Oct; 19(10):. PubMed ID: 30347827
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and antidepressant activity of novel 1-(1-benzoylpiperidin-4-yl) methanamine derivatives selectively targeting SSRI/5-HT
Yuan RX; Jiang KY; Wu JW; Zhang ZX; Li MS; Li JQ; Ni F
Bioorg Med Chem Lett; 2022 Nov; 76():129006. PubMed ID: 36202190
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and antidepressant-like activity of novel aralkyl piperazine derivatives targeting SSRI/5-HT
Gu ZS; Zhou AN; Xiao Y; Zhang QW; Li JQ
Eur J Med Chem; 2018 Jan; 144():701-715. PubMed ID: 29291438
[TBL] [Abstract][Full Text] [Related]
20. Synthesis of new hexahydro- and octahydropyrido[1,2-c]pyrimidine derivatives with an arylpiperazine moiety as ligands for 5-HT1A and 5-HT2A receptors.
Herold F; Kleps J; Wolska I; Nowak G
Farmaco; 2002 Dec; 57(12):959-71. PubMed ID: 12564469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
